rofecoxib has been researched along with Kidney Failure in 5 studies
Kidney Failure: A severe irreversible decline in the ability of kidneys to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rofecoxib (Vioxx) was withdrawn from the market because of increased death from cardiovascular (CV) events." | 2.43 | Cardiovascular issues of COX-2 inhibitors and NSAIDs. ( Chowienczyk, P; Kirkham, B; Wong, M, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wong, M | 1 |
| Chowienczyk, P | 1 |
| Kirkham, B | 1 |
| Wall, R | 1 |
| Strickland, C | 1 |
| Jamieson, B | 1 |
| Lo, V | 1 |
| Ofran, Y | 1 |
| Bursztyn, M | 1 |
| Ackerman, Z | 1 |
| Perazella, MA | 1 |
| Tray, K | 1 |
| Ahmad, SR | 1 |
| Kortepeter, C | 1 |
| Brinker, A | 1 |
| Chen, M | 1 |
| Beitz, J | 1 |
4 reviews available for rofecoxib and Kidney Failure
| Article | Year |
|---|---|
Cardiovascular issues of COX-2 inhibitors and NSAIDs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Clinical Protocols; Cyclooxygenase | 2005 |
Clinical inquiries. Do COX-2 inhibitors worsen renal function?
Topics: Arthritis, Rheumatoid; Celecoxib; Contraindications; Cyclooxygenase 2 Inhibitors; Humans; Kidney; La | 2007 |
Selective cyclooxygenase-2 inhibitors: a pattern of nephrotoxicity similar to traditional nonsteroidal anti-inflammatory drugs.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2; Cyclo | 2001 |
Renal failure associated with the use of celecoxib and rofecoxib.
Topics: Adverse Drug Reaction Reporting Systems; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Humans; | 2002 |
1 other study available for rofecoxib and Kidney Failure
| Article | Year |
|---|---|
Rofecoxib-induced renal dysfunction in a patient with compensated cirrhosis and heart failure.
Topics: Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female; Fibrosis; Heart Fa | 2001 |